http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
A study on microstructural and dielectric properties of Ba0.5-xZnxSr0.45Ca0.05TiO3 ceramics
Ying-Chieh Lee,Hui-Ju Hsu,I-Yu Huang,Huei-Jyun Shih,Christian Pithan 한양대학교 청정에너지연구소 2023 Journal of Ceramic Processing Research Vol.24 No.6
reaction process and sintered at temperatures ranging from 1150 °C to 1250 °C. The properties of these ceramics werefound to be significantly affected by variations in the Zn content. Densification of the BZSCT ceramics was observed to occurat sintering temperatures exceeding 1225 °C. Notably, the crystalline phases and dielectric properties of these ceramics werestrongly influenced by the Zn content. Three distinct secondary phases were identified in the BZSCT ceramics, includingBaZn2.03Ti3.93O10.89, Ba2ZnTi5O13 and Zn2TiO4. The addition of Zn resulted in a shift of the Curie point to lower temperatures. Specifically, with Zn substitution (up to 15 at.%), a Curie point of -60 °C was observed in the BZSCT ceramics. Theseceramics exhibited a high dielectric constant of 1035, a low dielectric loss of 0.017%, and an impressive Q value of 442 whensintered at 1225 °C. Moreover, when comparing the dielectric constants of BZSCT ceramics at 1 MHz and 1 GHz, it wasnoted that the permittivity was only slightly reduced by less than 30% at lower frequencies. In contrast, the permittivity ofBST ceramics decreased significantly, by approximately 70%, at microwave frequencies. These findings highlight the uniqueproperties and potential applications of BZSCT ceramics, particularly in microwave applications where they outperformtraditional BST ceramics.
( Jow Jyh Hwang ),( Ching Chu Lo ),( Chien Hung Lin ),( Hsu Sheng Cheng ),( I Wen Hung ),( Wan Ju Tsai ),( Chien Hui Hung ) The Editorial Office of Gut and Liver 2015 Gut and Liver Vol.9 No.2
Background/Aims: Hematological abnormalities during hepatitis C virus (HCV) combination therapy with pegylated interferon α and ribavirin often necessitate dose reduction. Variants of the ITPA gene have been reported to protect against anemia during the early stages of HCV combination treatments but have also been associated with larger decreases in platelet counts. We aimed to identify the association between specific ITPA gene polymorphisms and hematological abnormalities in patients undergoing HCV combination therapy. Methods: In this retrospective study, 175 patients treated with HCV combination therapy were enrolled at St. Martin De Porres Hospital in Taiwan between 2006 and 2012. Two single nucleotide polymorphisms (SNP) within or adjacent to the ITPA gene (rs1127354, rs6051702) were genotyped. We investigated the effect of ITPA gene variants on hematological abnormalities during the therapy. Results: The ITPA rs1127354 minor variants were significantly associated with protection against anemia at week 4 (p=1.86×10-6) and with more severe decreases in platelet counts during HCV combination therapy. SNP rs6051702 was not associated with the hemoglobin decline to >3 g/dL at week 4 in our study (p=0.055). Conclusions: The ITPA SNP rs1127354 is a useful predictor of ribavirin-induced anemia in Taiwanese patients and may be related to more severe decreases in platelet counts during the early stage of HCV combination therapy. (Gut Liver, 2015;9:214-223)